Google Scholar: citations
Affective alterations in patients with Cushing's syndrome in remission are associated with decreased BDNF and cortisone levels
Valassi, Elena (Institut d'Investigació Biomèdica Sant Pau)
Crespo, I. (Institut d'Investigació Biomèdica Sant Pau)
Keevil, B.G. (University Hospital of South Manchester)
Aulinas, Anna (Institut d'Investigació Biomèdica Sant Pau)
Urgell, E. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Santos, A. (Institut d'Investigació Biomèdica Sant Pau)
Trainer, P.J. (The Christie NHS Foundation Trust (Manchester, Regne Unit))
Webb, Susan M. 1952- (Institut d'Investigació Biomèdica Sant Pau)

Date: 2017
Abstract: Objective: Affective alterations and poorer quality of life often persist in patients with Cushing's syndrome (CS) in remission. Brain-derived neurotrophic factor (BDNF) regulates the hypothalamic-pituitary-adrenal axis (HPA) and is highly expressed in brain areas controlling mood and response to stress. Our aims were to assess affective alterations after long-term remission of CS and evaluate whether they are associated with serum BDNF, salivary cortisol (SalF) and/or cortisone (SalE) concentrations. Subjects and methods: Thirty-six CS patients in remission (32 females/4 males; mean age (±s. d. ), 48. 8 ± 11. 8 years; median duration of remission, 72 months) and 36 gender-, age- and BMI-matched controls were included. Beck Depression Inventory-II (BDI-II), Center for Epidemiological Studies Depression Scale (CES-D), Positive Affect Negative Affect Scale (PANAS), State-Trait Anxiety Inventory (STAI), Perceived Stress Scale (PSS) and EuroQoL and CushingQoL questionnaires were completed and measured to evaluate anxiety, depression, stress perception and quality of life (QoL) respectively. Salivary cortisol was measured using liquid chromatography/tandem mass spectrometry (LC/TMS). BDNF was measured in serum using an ELISA. Results: Remitted CS patients showed worse scores in all questionnaires than controls: STAI (P < 0. 001), BDI (P < 0. 001), CES-D (P < 0. 001), PANAS (P < 0. 01), PSS (P < 0. 01) and EuroQoL (P < 0. 01). A decrease in BDNF was observed in CS vs controls (P = 0. 038), and low BDNF was associated with more anxiety (r = -0. 247, P = 0. 037), depression (r = -0. 249, P = 0. 035), stress (r = -0. 277, P = 0. 019) and affective balance (r = 0. 243, P = 0. 04). Morning salivary cortisone was inversely associated with trait anxiety (r = -0. 377, P = 0. 040) and depressed affect (r = -0. 392, P = 0. 032) in CS patients. Delay to diagnosis was associated with depressive symptoms (BDI-II: r = 0. 398, P = 0. 036 and CES-D: r = 0. 449, P = 0. 017) and CushingQoL scoring (r = -0. 460, P < 0. 01). Conclusions: Low BDNF levels are associated with affective alterations in 'cured' CS patients, including depression, anxiety and impaired stress perception. Elevated levels of SalE might also be related to poor affective status in these patients.
Rights: Aquest material està protegit per drets d'autor i/o drets afins. Podeu utilitzar aquest material en funció del que permet la legislació de drets d'autor i drets afins d'aplicació al vostre cas. Per a d'altres usos heu d'obtenir permís del(s) titular(s) de drets.
Language: Anglès
Document: Article ; recerca ; Versió acceptada per publicar
Subject: Cushing's syndrome ; Anxiety ; Stress ; Depression ; BDNF ; Salivary cortisol ; Salivary cortisone
Published in: European journal of endocrinology, Vol. 176, Núm. 2 (February 2017) , p. 221-231, ISSN 1479-683X

DOI: 10.1530/EJE-16-0779


Postprint
35 p, 425.7 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles

 Record created 2025-01-24, last modified 2025-12-02



   Favorit i Compartir